---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-117492"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:56:22.250332+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed files 8-K furnishing Q4 2023 investor presentation

## Summary
- Company furnished investor presentation as Exhibit 99.1 for use at conferences.
- Presentation is furnished under Regulation FD and not deemed filed for liability purposes.
- CEO David P. Hochman signed the report on November 14, 2023.

## SEC filing metadata
- accession: 0001104659-23-117492
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000110465923117492/0001104659-23-117492-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000110465923117492/tm2330668d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-117492
- JSON: https://secwatch.observer/filing/0001104659-23-117492.json
- Plain text: https://secwatch.observer/filing/0001104659-23-117492.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.